Jove
Visualize
Contact Us

Related Experiment Videos

Catch the kinase conformer.

Campbell McInnes1, Mokdad Mezna, George Kontopidis

  • 1College of Pharmacy, University of South Carolina, Columbia, 29208, USA.

Chemistry & Biology
|July 29, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Repurposing Purine Analog Antivirals to Modulate Serum Uric Acid: Evidence From Real-World Data.

Clinical and translational science·2026
Same author

Comparative Analysis of Biochemical and Cellular Assay Conditions and the Need for a Buffer That Mimics Cytoplasmic Environments.

Molecules (Basel, Switzerland)·2025
Same author

Structural regulation of PLK1 activity: implications for cell cycle function and drug discovery.

Cancer gene therapy·2025
Same author

Reversible Small Molecule Multivariant Ras Inhibitors Display Tunable Affinity for the Active and Inactive Forms of Ras.

Journal of medicinal chemistry·2025
Same author

Overcoming Resistance to FLT3-ITD Therapeutics.

Journal of medicinal chemistry·2024
Same author

A highly potent bi-thiazole inhibitor of LOX rewires collagen architecture and enhances chemoresponse in triple-negative breast cancer.

Cell chemical biology·2024
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Protein kinases have active and inactive forms, but drug discovery often overlooks targeting the inactive state. This study demonstrates that specific inhibitors can be designed to target inactive Abl kinase.

Area of Science:

  • Biochemistry
  • Drug Discovery
  • Molecular Biology

Background:

  • Protein kinases exist in distinct active and inactive conformational states.
  • The choice of targeting active versus inactive kinase states in drug discovery is often underexplored.
  • Abl kinase is a critical target in various diseases, necessitating precise inhibitor design.

Discussion:

  • This research investigates the potential of targeting the inactive conformation of protein kinases.
  • The study by Okram et al. specifically focuses on designing inhibitors for inactive Abl kinase.
  • Understanding kinase conformational dynamics is crucial for developing selective therapeutics.

Key Insights:

  • Inhibitors can be specifically engineered to bind to the inactive state of Abl kinase.

Related Experiment Videos

  • This approach offers a novel strategy for kinase-targeted drug development.
  • Selective targeting of inactive kinases may reduce off-target effects and improve therapeutic efficacy.

    • Outlook:

    • Further exploration of targeting inactive kinase states could lead to more effective and safer drugs.
    • This work may pave the way for developing inhibitors against other kinase targets in their inactive conformations.
    • Future research should validate the therapeutic potential of inactive-state specific inhibitors in preclinical models.